177 related articles for article (PubMed ID: 31199578)
1. Protective effects of glucagon-like peptide-1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus.
Wang D; Jiang L; Feng B; He N; Zhang Y; Ye H
J Diabetes Investig; 2020 Jan; 11(1):39-51. PubMed ID: 31199578
[TBL] [Abstract][Full Text] [Related]
2. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.
Yang S; Lin C; Zhuo X; Wang J; Rao S; Xu W; Cheng Y; Yang L
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1019-E1030. PubMed ID: 32985256
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
[TBL] [Abstract][Full Text] [Related]
6. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
[TBL] [Abstract][Full Text] [Related]
8. ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal Pathway.
Li S; Wu H; Han D; Zhang M; Li N; Yu W; Sun D; Sun Z; Ma S; Gao E; Li C; Shen M; Cao F
Oxid Med Cell Longev; 2018; 2018():6451902. PubMed ID: 29576852
[TBL] [Abstract][Full Text] [Related]
9. Testicular cytoprotective effect of glucagon like peptide-1 in diabetic rats involves inhibition of apoptosis, endoplasmic reticulum stress and activation of autophagy.
Abdel-Hakeem EA; Zenhom NM; Mokhemer SA
Gen Physiol Biophys; 2023 Mar; 42(2):135-148. PubMed ID: 36896943
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes.
Balteau M; Van Steenbergen A; Timmermans AD; Dessy C; Behets-Wydemans G; Tajeddine N; Castanares-Zapatero D; Gilon P; Vanoverschelde JL; Horman S; Hue L; Bertrand L; Beauloye C
Am J Physiol Heart Circ Physiol; 2014 Oct; 307(8):H1120-33. PubMed ID: 25128166
[TBL] [Abstract][Full Text] [Related]
12. [Effects and mechanism of glycine on rat cardiomyocytes pretreated with serum from burned rats].
Lyu SJ; Yan ZD; Fan RH; Peng X
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 May; 39(5):434-442. PubMed ID: 37805752
[No Abstract] [Full Text] [Related]
13. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
[TBL] [Abstract][Full Text] [Related]
16. Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals.
Wang Y; Cai F; Li G; Tao Y
Bioengineered; 2022 Apr; 13(4):9184-9196. PubMed ID: 35383532
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
[TBL] [Abstract][Full Text] [Related]
18. The GLP-1 analogue liraglutide protects cardiomyocytes from high glucose-induced apoptosis by activating the Epac-1/Akt pathway.
Wu XM; Ou QY; Zhao W; Liu J; Zhang H
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):608-14. PubMed ID: 25140997
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
20. [Protective effect of salidroside on high fat-induced apoptosis in H9c2 cardiomyocytes through AMPK/mTOR/p70S6K pathway].
Wu MZ; Xiang Y; Bao CY; Liu T
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3837-3843. PubMed ID: 35850842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
